IARC – INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
The closing date for nominations of agents for consideration by the Advisory Group .. series, with free access to PDFs of published volumes and lists of evaluations for all We are pleased to announce that Volume of the IARC Monographs was Now available: IARC Monographs List of Classifications by Cancer Site. Updating of IARC Monographs Volumes 1 to 42), Saccharin, pp. . impossible to absolutely conclude that it poses no threat to human health, sodium . benign tumors: (1) in multiple species or at multiple tissue sites, or (2)by yr-old) women who reported using AS more than times (Odds Ratio .. sex, discharge date. Although there are plenty of sites that claim they are % online free dating sites, most aren't. There are, however, semi-free dating sites.
As an example, the structures of IMSS and ISSSTE should function to enable referencing and counter-referencing and should mediate the granting of early treatment within their system, but that is not the case.
IARC Monographs – News – IARC
The situation is worse in other sectors, such as SSalud, which does not have a second level of attention allowing for patient monitoring, therefore saturating hospitals with high degrees of speciality. For this reason, the accreditation of feasible actions for all institutions must be the first step. The deficient infrastructure available in the country has been mentioned above; for instance, inthe existence of certified medical oncologists for a population of over million people was reported.
Additionally, medical specialists are centralized in the larger cities in the country: However, most tumors in Mexico are diagnosed in advanced stages, reflecting the lack of knowledge of health staff and the general population as well as the poor distribution of screening programs in these sectors.
IARC Monographs – News
Thus, the Mexican health system has serious deficiencies in its physical infrastructure and personnel that will be difficult to amend in the short term.
The NCCP should be implemented under the current conditions, and the challenge is to ensure that active cross-sectoral and community collaborations promote effective changes in the lifestyles of the population and in the detection and care to reduce cancer morbidity and mortality in the long term.
In addition to these factors, it is impossible that the huge economic costs associated with cancer can be exclusively undertaken by the public sector and are even less likely to be assumed by individual families.
Thus the financing, construction, renovation, management and maintenance of the needed infrastructures for cancer care require the involvement of other sectors, especially the private sector.
In this context, it is necessary to define a clear framework and a methodology for the collaboration between public and private stakeholders in the health system. The creation of a cross-sectoral coordinating body may contribute to the better design, implementation and evaluation of all of these proposed actions.
A link between the government sector and a cross-sectoral working task force with actors with technical, academic and research profiles is needed to advance toward key objectives, as has been achieved in some other nations.
Achieving the sustainability of the integrated management of NCDs, including cancer, represents a huge challenge for the health system in Mexico. The economic component is of great importance for both the health system itself and the macroeconomics of the country. To gauge the economic impact that cancer will have on our country, estimations of cancer's macroeconomic impact i. According to the current trends of mortality and incidence-prevalence and due to the non-strengthening of prevention and early diagnosis interventions, the macroeconomic cost of cancer is estimated to be at just over 50 billion pesos mp by In the second scenario, the indirect cost generated by cancer in PEAOA amounts to just over million pesos in In the absence of prevention and early diagnosis interventions, it is estimated that the macroeconomic cost of cancers would reach million pesos inthen requiring cancer prevention and early detection action in adults, which will contribute to the financial sustainability of comprehensive care cancer in the medium and long term.
The care and treatment of some cancers in people without Social Security are covered by the Seguro Popular in Mexico. However, the general population does not have full coverage in the care of other types of cancers.
This recent opening of financial protection creates great pressure on the health system to meet the treatment needs of people with cancer. The FPGCC, created for this purpose, provides health care to accredited patients through a network of centers that do not have national coverage, and the attention it provides has other limitations, such as insufficient numbers of specialists and technical staff for the operation and maintenance of radiotherapy and brachytherapy equipment.
Therefore, the policy of BC treatment inclusion in the FPGC is negatively affected by the lack of an equally wide policy on prevention and early detection. This reality has led to the exploration of options for increasing the use of the first- and second-level centers, along with private health care facilities, through systems of co-responsibility and schemes of negotiated prices.
Agents Classified by the IARC Monographs, Volumes 1–123
The increase in demand for care, which is a product of this strategy, should foster better price negotiations for both drugs and treatments. Similarly, the implementation of a program of this magnitude should consider its evaluation via a transparency and accountability method, for which a statistical information system that calculates the incidence, prevalence, survival and quality of life of cancer patients is needed.
These measures are essential to the institution of population-based cancer registries, one of the most urgent needs of the country and a central part of the NCCP. Therefore, generating an inclusive program that is standardized under equity standards that promote greater survival and improved quality of life for patients is an urgent task in Mexico.
These measures will require the effort of the national health system to face the challenges posed here and to have positive effects on the incidence and mortality of one of the leading causes of mortality in the country: International Agency for Research on Cancer, [accesed on August 30, ].
Observatorio de la Salud Global. WHO [internet site]. WHO, [accessed on September 19, ]. UICC [internet site]. Geneva, Switzerland [accessed on September 20, ].
National Cancer Control Programmes: International Agency for Research on Cancer, [accessed on September 27, ]. Australian Institute of Health and Welfare Cancer survival and prevalence in Australia: Cancer Mortality in the UK in [internet site].
London, [accesed on September 22, ]. England and Wales Survival Summary [internet document]. Cancer Research UK, [accessed on December 15, ]. Centers for Disease Control and Prevention.
Cancer by Race and Ethnicity [internet site]. CDC, [accesed on September 22, ]. Estimates of global cancer prevalence for 27 sites in the adult population in Int J Cancer ; 5: International Agency for Research on Cancer, [accessed on August 30, ].
Departamento de Salud de Puerto Rico, Ministerio de Salud, Ministerio de la Salud, Encuesta Nacional de Salud y Nutricion Identification of malignant breast lesions in Mexico. Salud Publica Mex ; Sistema de Seguridad Social en Salud.
Informe de resultados Salud Publica Mex ;53 supl 2: Center for Workforce Studies Encuesta Nacional de Adicciones Fruit and vegetable intake in the Mexican population: Salud Publica Mex ;51 sup 4: WHO guide for effective programmes. Primer informe sobre combate al tabaquismo. Acuerdo Nacional para la Salud Alimentaria. Estrategia de sobrepeso y obesidad. ISBN [accessed on December ].
July 03, ; Accepted: Diazinon, Glyphosate, Malathion, Parathion, and Tetrachlorvinphos We are pleased to announce that the Monographs on Malathion and Diazinon are now available online. Red Meat and Processed Meat Following random reports today Friday 23 October in the British press postulating on the outcome of the IARC evaluation on the carcinogenicity of red meat and processed meat, please note that there was NO breach of embargo, as no embargoed material was shared with any news outlet, in Britain or elsewhere.
The anticipated publication date is Monday 26 October Some Organophosphate Insecticides and Herbicides We are pleased to announce that the Monograph on glyphosate is now available online. Read the IARC press release. This user-friendly, searchable format allows all the agents evaluated in Volumes 1— to be sorted by name, group, CAS number, Monograph volume, and year. The remaining Monographs of volume will be published subsequently. For details, please see Information on nominations.
Some Drugs and Herbal Products We are pleased to announce that the Monographs on Pioglitazone and rosiglitazone, and Digoxin, are now available online. The remaining Monographs will be published subsequently. Read the IARC news item. These instructions should be read in conjunction with the Preamble to the IARC Monographswhich provides guidelines for the selection, evaluation, and integration of data for the Monographs.
Polychlorinated Biphenyls and Polybrominated Biphenyls We are pleased to announce that the Monograph on Polybrominated Biphenyls is now available online. The accompanying Monograph on Polychlorinated Biphenyls will be published subsequently.